Myriad Genetics
MYGN
MYGN
227 hedge funds and large institutions have $2.15B invested in Myriad Genetics in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 78 increasing their positions, 73 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
227
Holders Change
+6
Holders Change %
+2.71%
% of All Funds
4.48%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
30
Increased
78
Reduced
73
Closed
19
Calls
$8.74M
Puts
$13.9M
Net Calls
-$5.15M
Net Calls Change
-$3M
Top Buyers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$73.7M |
| 2 |
2
Morgan Stanley
New York
|
$51M |
| 3 |
3
Millennium Management
New York
|
$20.1M |
| 4 |
4
D.E. Shaw & Co
New York
|
$78.1M |
| 5 |
5
Barclays
London,
United Kingdom
|
$10.9M |
